Chemical Structure : IK-930
CAS No.: 2563892-44-2
Catalog No.: PC-20406Not For Human Use, Lab Use Only.
IK-930 (IK930) is a selective, oral TEAD inhibitor that selectively inhibits TEAD-dependent transcription by directly blocking autopalmitoylation.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $98 | In stock | |
25 mg | $158 | In stock | |
50 mg | $258 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IK-930 (IK930) is a selective, oral TEAD inhibitor that selectively inhibits TEAD-dependent transcription by directly blocking autopalmitoylation.
IK-930 is inactive in a broad panel of kinases, receptors, and transporters, furthering evidence of selectivity.
IK-930 inhibits in vitro proliferation of Hippo pathway-deficient cancer cell lines, but not Hippo pathway wild type cells.
IK-930 demonstrates antitumor activity in mouse xenograft models with Hippo pathway genetic alterations.
IK-930 enhances apoptosis and in vivo antitumor activity in combination with EGFR and MEK inhibitors, respectively, in EGFR or KRAS mutated tumors.
M.Wt | 424.44 | |
Formula | C19H19F3N4O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzenesulfonamide, N-methyl-3-(1-methyl-1H-imidazol-4-yl)-4-[[[4-(trifluoromethyl)phenyl]methyl]amino]- |
1. Benjamin S. Amidon, et al. Cancer Res (2022) 82 (12_Supplement): 2156.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright